Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Montes Borinaga, A."'
Autor:
Montes Borinaga, A.
Publikováno v:
In FMC. Formación médica continuada en atención primaria August-September 2002 9(7):546-551
Autor:
Gala Serrano Bermúdez, Ferrán Guedea Edo, Maria Dolores Arnaiz Fernandez, Branislav Jeremic, Ana Montes Borinaga, Valentí Navarro Pérez, Ana Lucas Calduch, Sol San José Maderuelo, Felipe Cardenal Alemany
Publikováno v:
Clinical and Translational Oncology. 7:314-320
We retrospectively reviewed our institution’s database to investigate the outcome and impact of combined radiochemotherapy (RT/CT; concomitant or in sequence) in localised small-cell lung cancer (L-SCLC). Between January 1995 to November 1999, 79 p
Autor:
A. Montes Borinaga
Publikováno v:
FMC - Formación Médica Continuada en Atención Primaria. 9:546-551
Autor:
A. Montes Borinaga, R. Gooding, P. Riches, J. B. G. Bell, B. C. Millar, T. J. McElwain, John L. Millar, J. K. Joffe
Publikováno v:
British Journal of Haematology. 76:476-483
Several groups have claimed that IL-6 is a growth factor for human myeloma cells in vitro. Bone marrow aspirates from 30 patients at different stages of treatment with VAMP/high dose melphalan, were examined for myeloma colony formation (MY-CFUc) usi
Autor:
Johnathan Joffe, J. B. G. Bell, C. Viner, B. C. Millar, A. Montes-Borinaga, David Cunningham, T. J. McElwain, Janine Mansi, Jennifer Treleaven
Publikováno v:
Hematological Oncology. 8:347-353
A study of 32 patients receiving cyclophosphamide (CY) and verapamil (VER) in addition to the drug combination vincristine, adriamycin and methyl prednisolone (VAMP) was made in which the clinical response and growth of clonogenic myeloma cells (MY-C
Autor:
Corcuera Frutos, I. Díaz de, Elez Fernández, E., Barretina Gisnesta, P., Jiménez Colomo, L., Montes Borinaga, A., Germá Lluch, J. R.
Publikováno v:
Oncología (Barcelona), Volume: 30, Issue: 2, Pages: 48-52, Published: 2007
El carcinoma ovárico de célula pequeña hipercalcémico es un tumor raro y agresivo con mayor incidencia en mujeres jóvenes. La hipercalcemia es una de sus características clínicas. El tratamiento multidisciplinar parece incrementar la supervive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______624::ed466eb8312fb897b4e60f0cbbd43ed8
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352007000200005&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0378-48352007000200005&lng=en&tlng=en
Autor:
A. Montes Borinaga, E. Elez Fernández, J. R. Germá Lluch, L. Jiménez Colomo, I. Díaz de Corcuera Frutos, P. Barretina Gisnesta
Publikováno v:
Oncología (Barcelona) v.30 n.2 2007
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
El carcinoma ovárico de célula pequeña hipercalcémico es un tumor raro y agresivo con mayor incidencia en mujeres jóvenes. La hipercalcemia es una de sus características clínicas. El tratamiento multidisciplinar parece incrementar la supervive
Autor:
Ana, Lucas Calduch, María Dolores, Arnaiz Fernández, Sol, San José Maderuelo, Valentí, Navarro Pérez, Gala, Serrano Bermúdez, Ana, Montes Borinaga, Felipe, Cardenal Alemany, Branislav, Jeremic, Ferran, Guedea Edo
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(7)
We retrospectively reviewed our Institution's database to investigate the outcome and impact of combined radiochemotherapy (RT/CT; concomitant or in sequence) in localised small-cell lung cancer (L-SCLC).Between January 1995 to November 1999, 79 pati
Autor:
Montes Borinaga, A., Millar, B. C., Bell, J. B. G., Joffe, J. K., Millar, J. L., Gooding, R., Riches, P., McElwain, T. J.
Publikováno v:
British Journal of Haematology; Dec1990, Vol. 76 Issue 4, p476-483, 8p
Autor:
Bell, J. B. G., Millar, B. C., Montes-Borinaga, A., Joffe, J. K., Cunningham, D., Mansi, J., Treleaven, J., Viner, C., McElwain, T. J., Bell, J B
Publikováno v:
Hematological Oncology; Nov1990, Vol. 8 Issue 6, p347-353, 7p